PATENT CLAIM ANALYSIS

Application Number: 15742408
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["435", "006110"]

Abstract:
The present invention relates to a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. According to the present invention, a colorectal treatment effect can be maximized by sorting patients having sensitivity to the simultaneous inhibitor against PARP and Tankyrase.

Claim (Index 8):
The kit according to  claim 7 , wherein the nucleotide sequence encoding the p53 gene is represented by SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09813824', '09174493', '11679803', '10555507', '13952561']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6232956388366896
- 35 USC 102 Novelty (BERT): 0.5018024061319042
- Combined Prediction Score: 0.611146315566211
- Mean Citation Score: 239.035248
- Max Citation Score: 244.26163
- Similarity Product: 163.79922771288338

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test